Back to Search
Start Over
The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.
- Source :
-
Haematologica [Haematologica] 2015 Apr; Vol. 100 (4), pp. e147-51. Date of Electronic Publication: 2014 Dec 31. - Publication Year :
- 2015
- Subjects :
- Antibodies, Monoclonal, Murine-Derived pharmacology
Antigens, CD20 metabolism
Antineoplastic Agents pharmacology
Cytotoxicity, Immunologic
Humans
Immunologic Factors pharmacology
Killer Cells, Natural metabolism
Lymphocyte Subsets drug effects
Lymphocyte Subsets immunology
Lymphocyte Subsets metabolism
Rituximab
Antibodies, Monoclonal, Murine-Derived therapeutic use
Antineoplastic Agents therapeutic use
Immunologic Factors therapeutic use
Killer Cells, Natural drug effects
Killer Cells, Natural immunology
Waldenstrom Macroglobulinemia drug therapy
Waldenstrom Macroglobulinemia immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 100
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Report
- Accession number :
- 25552707
- Full Text :
- https://doi.org/10.3324/haematol.2014.118083